VERTEX PHARMACEUTICALS INC / MA Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Vertex Pharmaceuticals Inc / Ma Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $267M, a 12.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $267M +$28.8M +12.1% Dec 31, 2023 10-K 2024-02-15
Q4 2022 $238M +$17.4M +7.9% Dec 31, 2022 10-K 2024-02-15
Q4 2021 $220M +$6.6M +3.09% Dec 31, 2021 10-K 2023-02-10
Q4 2020 $214M +$8.61M +4.2% Dec 31, 2020 10-K 2022-02-09
Q4 2019 $205M +$36.7M +21.8% Dec 31, 2019 10-K 2021-02-11
Q4 2018 $168M -$1.38B -89.2% Dec 31, 2018 10-K 2020-02-13
Q3 2018 $205M Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $205M Jun 30, 2018 10-Q 2018-07-26
Q1 2018 $205M Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $1.55B -$178M -10.3% Dec 31, 2017 10-K 2019-02-13
Q4 2016 $1.73B +$14.8M +0.86% Dec 31, 2016 10-K 2018-02-15
Q4 2015 $1.72B +$306M +21.7% Dec 31, 2015 10-K 2017-02-23
Q4 2014 $1.41B +$166M +13.4% Dec 31, 2014 10-K 2016-02-16
Q4 2013 $1.24B +$32.1M +2.65% Dec 31, 2013 10-K 2015-02-13
Q4 2012 $1.21B -$118M -8.89% Dec 31, 2012 10-K 2014-02-11
Q4 2011 $1.33B -$38.4M -2.8% Dec 31, 2011 10-K 2013-03-01
Q4 2010 $1.37B Dec 31, 2010 10-K 2012-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.